Mizuho analyst Steven Valiquette raised the firm’s price target on Henry Schein (HSIC) to $78 from $75 and keeps a Neutral rating on the shares. The company reported preliminary Q4 results that are “somewhat disappointing” but the news that KKR is making a 12% strategic investment and also receiving two board seats will likely be viewed favorably by investors, the analyst tells investors in a research note.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSIC:
- Henry Schein price target raised to $90 from $82 at Barrington
- Henry Schein Partners with KKR for Strategic Growth
- Early notable gainers among liquid option names on January 29th
- Henry Schein reports preliminary Q4 EPS $1.19, consensus $1.23
- Henry Schein announces $250M strategic investment by KKR, board changes